iBio Inc (IBIO)

Nov 15, 2024

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Nov 15, 2024

Nov 15, 2024

Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Nov 14, 2024

Nov 13, 2024

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 13, 2024

Nov 12, 2024

iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 12, 2024

Nov 12, 2024

iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World

Nov 12, 2024

Nov 11, 2024

iBio Inc. stock remains steady Monday, underperforms market - MarketWatch

Nov 11, 2024

Oct 28, 2024

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Oct 28, 2024

Oct 23, 2024

iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks

Oct 23, 2024

Oct 21, 2024

Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR

Oct 21, 2024

Oct 17, 2024

iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch

Oct 17, 2024

Oct 16, 2024

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Oct 16, 2024

Oct 14, 2024

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Oct 14, 2024

Oct 14, 2024

Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments - GlobeNewswire Inc.

Oct 14, 2024

Oct 11, 2024

Lead molecule identified under Ibio and Astralbio’s myostatin program for obesity - BioWorld Online

Oct 11, 2024

Oct 11, 2024

Items Tagged with 'Astralbio Inc.' - BioWorld Online

Oct 11, 2024

Oct 10, 2024

iBio and AstralBio Provide Update on Myostatin Program for Obesity - GlobeNewswire

Oct 10, 2024

Oct 10, 2024

IBio, Inc. and AstralBio Provide Update on Myostatin Program for Obesity - Marketscreener.com

Oct 10, 2024

Oct 08, 2024

IBIO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 08, 2024

Oct 07, 2024

What is going on with iBio Inc? Sentiment Analysis - US Post News

Oct 07, 2024

Oct 04, 2024

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Oct 04, 2024

Oct 03, 2024

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Oct 03, 2024

Oct 01, 2024

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Oct 01, 2024

Sep 26, 2024

iBio (NYSE:IBIO) Trading 1.6% Higher - Defense World

Sep 26, 2024

Sep 24, 2024

Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha

Sep 24, 2024

Sep 24, 2024

Biafra: Why We Ended Nnamdi Kanu’s Trial – Lawyer Ejimakor - Tori.ng

Sep 24, 2024

Sep 24, 2024

Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex

Sep 24, 2024

Sep 23, 2024

Immunome (NASDAQ:IMNM) Shares Down 5.6% After Insider Selling - MarketBeat

Sep 23, 2024

Sep 23, 2024

IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News

Sep 23, 2024

Sep 23, 2024

Imac Holdings stock hits 52-week low at $1.2 amid market challenges - Investing.com

Sep 23, 2024

Sep 23, 2024

Biotech Boom Ahead? Key Stocks and ETFs to Watch Now - MarketBeat

Sep 23, 2024